Designing a next-generation Chikungunya virus vaccine through integrated immunoinformatics and computational approaches
Year: 2026
Type: article
Abstract: Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that can cause fever, severe joint pain and neurological complications. Although vaccines against CHIKV are available in some regions there is still a need for additional vaccine strategies. In this study we used a computational immunoinformatic approach to design a multi-epitope vaccine candidate from the CHIKV structural polyprotein. B-cell epitopes and MHC-I and MHC-II epitopes were identified and screened for antigenicity, immunogenicity, allergenicity and toxicity. The selected epitopes were joined using suitable linkers and a 50 S ribosomal L7/L12 protein was added as an adjuvant. The final construct showed favourable predicted physicochemical and structural properties with an antigenicity score of 0.524. It was also predicted to be non-allergenic and non-toxic. Molecular docking showed favourable interaction with TLR-9, and a 200 ns molecular dynamics simulation indicated stability of the modelled vaccine–receptor complex. Immune simulation predicted both humoral and cellular immune responses. Overall, this study provides a computationally designed CHIKV multi-epitope vaccine candidate that can be considered for further experimental evaluation. In vitro and in vivo studies are needed to confirm its safety, immunogenicity and protective efficacy.
Source: Scientific Reports
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,690
Funder: King Saud University
Award: G9001369173
OpenAlex ID: W7226498535
